Value of PD-L1 positive CTCs as predictive marker of pCR during neoadjuvant chemotherapy in locally advanced breast cancer. Correlation with BRCA1/2 germline mutation. Inviato da Anonimo (non verificato) il Lun, 11/04/2022 - 12:48
Telomere Biology Disorders and Nuclear Boundaries: focus on the role on the ESCRT machinery Inviato da Anonimo (non verificato) il Lun, 11/04/2022 - 12:48